Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVT8 | ISIN: CH1125843347 | Ticker-Symbol: 90B
Tradegate
27.06.25 | 15:39
2,640 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SOPHIA GENETICS SA Chart 1 Jahr
5-Tage-Chart
SOPHIA GENETICS SA 5-Tage-Chart
RealtimeGeldBriefZeit
2,6202,68013:02
2,5602,72027.06.

Aktuelle News zur SOPHIA GENETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSophia Genetics launches podcast to decode data- and AI-driven medical innovation2
18.06.SOPHiA GENETICS SA - 6-K, Report of foreign issuer2
27.05.MEXC lists SOPH with $40K SOPH and $50K USDT prize pool2
27.05.MEXC Announces the Listing of Sophon (SOPH) with $40,000 in SOPH and 50,000 USDT Prize Pool342VICTORIA, Seychelles, May 27, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, will list Sophon (SOPH) on May 28, 2025 (UTC).To celebrate the listing, MEXC is launching...
► Artikel lesen
16.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer1
06.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer3
06.05.SOPHiA GENETICS Reports First Quarter 2025 Results151BOSTON and ROLLE, Switzerland, May 6, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
28.04.SOPHia Genetics expands testing partnership with AstraZeneca4
SOPHIA GENETICS Aktie jetzt für 0€ handeln
28.04.SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR306BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today...
► Artikel lesen
28.04.SOPHiA GENETICS expands AstraZeneca liquid biopsy test3
28.04.SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR143BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader...
► Artikel lesen
08.04.Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern66Die Partnerschaft integriert fortschrittliche KI-gesteuerte Analysen und Lösungen für klinische Studien und ermöglicht es Biopharmaunternehmen, die Entwicklung von...
► Artikel lesen
08.04.Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy Capabilities301The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. BETHESDA...
► Artikel lesen
18.03.SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC349BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic...
► Artikel lesen
05.03.BTIG cuts Sophia Genetics stock price target to $5, maintains buy4
04.03.SOPHiA Genetics reports mixed Q4 results; initiates FY25 outlook1
04.03.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results304BOSTON and ROLLE, Switzerland, March 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
04.03.SOPHiA GENETICS SA - 20-F, Annual and transition report of foreign private issuers-
04.03.SOPHiA GENETICS SA - 6-K, Report of foreign issuer-
24.02.SOPHiA GENETICS: Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing675SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq:...
► Artikel lesen
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1